or Try an Advanced Search...

    Rare Diseases Stocks List

    Symbol Grade Name % Change
    TAK F Takeda Pharmaceutical Company Limited 0.84
    INM F InMed Pharmaceuticals Inc. 0.69
    BLUE F bluebird bio, Inc. 2.50
    CNTG F Centogene N.V. 4.76
    ABEO F Abeona Therapeutics Inc. -5.56
    LXEO F Lexeo Therapeutics, Inc. -1.20
    QNCX F Quince Therapeutics, Inc. -7.16
    LIFE F aTyr Pharma, Inc. 1.27
    AKTX F Akari Therapeutics Plc 10.39
    RCEL F Avita Medical Limited 2.98
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Cancer Dystrophy Muscular Dystrophy Pharmacy Acid Biology Clinical Development Duchenne Duchenne Muscular Dystrophy Myopathy Alzheimer's Disease Amphetamine Amyotrophic Lateral Sclerosis Antisense RNA Arcturus Therapeutics Attention Deficit Hyperactivity Disorder Biologics

    Related ETFs - A few ETFs which own one or more of the above listed Rare Diseases stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 4.95
    TMFS B Motley Fool Small-Cap Growth ETF 2.98
    TMFM B Motley Fool Mid-Cap Growth ETF 2.09
    BBP C BioShares Biotechnology Products Fund 2.01
    LABD C Direxion Daily S&P Biotech Bear 3X Shares 1.49
    View all Rare Diseases ETFs...
    Compare ETFs
    Compare BBP to LABD Compare GNOM to BBP Compare TMFM to BBP

        Rare Diseases Stocks Recent News

        Date Stock Title
        May 1 AKTX Akari gains despite leadership change amid portfolio shakeup
        May 1 AKTX Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
        May 1 AKTX Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
        Apr 29 TAK Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
        Apr 29 LXEO IPO Roundup: Viking Holdings, RanMarine Technology, and more
        Apr 26 BLUE bluebird bio receives non-compliance notice from Nasdaq
        Apr 26 BLUE bluebird bio Announces Receipt of Expected Notice from Nasdaq
        Apr 26 TAK Bristol, Sanofi, Takeda gain positive CHMP recommendations
        Apr 26 TAK Down -5.9% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
        Apr 26 TAK HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
        Apr 26 TAK Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
        Apr 25 TAK Takeda said to have left industry trade group BIO
        Apr 25 TAK All You Need to Know About Takeda Pharmaceutical Co. (TAK) Rating Upgrade to Strong Buy
        Apr 25 TAK TAK or CTLT: Which Is the Better Value Stock Right Now?
        Apr 25 TAK 20 Fastest Growing Health Tech Companies in the World
        Apr 25 ABEO ABEO: Receives CRL Based on Need for More CMC Information…
        Apr 25 TAK New Strong Buy Stocks for April 25th
        Apr 25 TAK Best Value Stocks to Buy for April 25th
        Apr 25 TAK Best Income Stocks to Buy for April 25th
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Biopharmaceutical Biotechnology Medicine Biology Clinical Research Life Sciences Medical Genetics Cancer Dermatology Drug Discovery Dystrophy Gene Delivery Gene Therapy Genodermatoses Infectious Diseases Influenza Virotherapy Achondroplasia Acid Aesthetics
        Rare Diseases

        Rare diseases are medical conditions that affect a small percentage of the population. They are often genetic, chronic, and progressive, and can cause significant physical and mental disability. There are over 7,000 rare diseases, and many of them have no known cure.

        Browse All Tags